phrykt

Johnson & Johnson (JNJ): who owns it and who trades it

As of Nov 16, 2026, JNJ insiders reported 29 open-market sales worth $154M and 1 purchase worth $258K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Joaquin Duato (CEO), with $66.8M. 10 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Johnson & Johnson

From the latest filings

Overall: more selling than buying. Insiders and Congress mostly sold. Funds and famous investors were close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns JNJ

4,651 funds and institutions reported JNJ shares worth $456B at the end of Q2 2026, about 75% of the company. The largest holder is BlackRock, Inc. with 8.8%.

Funds and institutions (13F) 75%Everyone else 25%

10 largest owners, by share of the company

BlackRock, Inc.8.8%
Vanguard Capital Management LLC6.5%
State Street Corp5.6%
Vanguard Portfolio Management LLC2.7%
Geode Capital Management, LLC2.5%
JPMorgan Chase & Co2.4%
Morgan Stanley1.9%
Norges Bank1.3%
State Farm Mutual Automobile Insurance Co1.3%
Northern Trust Corp1.2%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.212.10M8.81%$53.9B-1%
Vanguard Capital Management LLC157.23M6.53%$39.9B+0%
State Street Corp133.78M5.56%$34B+0%
Vanguard Portfolio Management LLC64.37M2.67%$16.3B+1%
Geode Capital Management, LLC59.09M2.45%$15B-0%
JPMorgan Chase & Co58.30M2.42%$15.1B–
Morgan Stanley44.81M1.86%$11.4B+0%
Norges Bank31.83M1.32%$8.1B–
State Farm Mutual Automobile Insurance Co31.59M1.31%$8BNo change
Northern Trust Corp28.79M1.20%$7.3B-2%
Bank of America Corp23.44M0.97%$6B-8%
T. Rowe Price Associates23.00M0.96%$5.8B+39%
FMR LLC (Fidelity)22.60M0.94%$5.7B-9%
Wellington Management Group LLP22.59M0.94%$5.7B+13%
Bank of New York Mellon Corp21.68M0.90%$5.5B-1%
Goldman Sachs Group Inc19.72M0.82%$5B+9%
Legal & General Group Plc19.29M0.80%$4.9B-0%
Charles Schwab Investment Management Inc19.13M0.79%$4.9B-0%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC18.42M0.77%$4.7B-6%
Wells Fargo & Company17.37M0.72%$4.4B+3%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, JNJ insiders reported $258K of open-market purchases and $154M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$258K
1 trades, 1 people
Sales, 12 months
$154M
29 trades, 10 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Nov 12, 2026
Filed Nov 13, 2026

Purchases and sales by month

$58.4M$58.4MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 12, 2026Elizabeth ForminardVice presidentSale13,072$284.39$3.7MForm 4
Sep 2, 2026Timothy SchmidVice presidentSale22,527$274.74$6.2MForm 4
Sep 2, 2026Timothy SchmidVice presidentSale11,070$274.74$3MForm 4
Aug 17, 2026Jennifer L TaubertVice presidentSale15,000$263.36$4MForm 4
Aug 13, 2026Joaquin DuatoCEOSale20,976$262.00$5.5MForm 4
Aug 13, 2026Joaquin DuatoCEOSale102,315$261.00$26.7MForm 4
Aug 6, 2026Elizabeth ForminardVice presidentSale6,574$255.93$1.7MForm 4
Aug 6, 2026Elizabeth ForminardVice presidentSale9,344$257.76$2.4MForm 4
Aug 5, 2026Joaquin DuatoCEOSale41,957$258.06$10.8MForm 4
Aug 5, 2026Joaquin DuatoCEOSale6,523$258.74$1.7MForm 4
Jul 20, 2026Vanessa BroadhurstVice presidentSale23,054$251.27$5.8MForm 4
Jun 11, 2026Kathryn E WengelVice presidentSale10,000$241.15$2.4MForm 4
Feb 27, 2026Robert J DeckerVice presidentSale4,075$247.87$1MForm 4
Feb 20, 2026Timothy SchmidVice presidentSale1,322$245.66$325KForm 4
Feb 18, 2026Timothy SchmidVice presidentSale8,998$244.53$2.2MForm 4
Feb 18, 2026Timothy SchmidVice presidentSale13,625$244.20$3.3MForm 4
Feb 17, 2026James D. SwansonVice presidentSale20,521$242.70$5MForm 4
Feb 17, 2026Joseph J WolkCFOSale19,241$242.99$4.7MForm 4
Feb 17, 2026Joseph J WolkCFOSale24,961$242.68$6.1MForm 4
Feb 17, 2026Joseph J WolkCFOSale33,386$242.75$8.1MForm 4
Feb 17, 2026Joseph J WolkCFOSale12,066$242.87$2.9MForm 4
Feb 17, 2026John C ReedVice presidentSale29,927$243.00$7.3MForm 4
Feb 17, 2026John C ReedVice presidentSale2,283$243.00$555KForm 4
Feb 17, 2026John C ReedVice presidentSale21,721$243.00$5.3MForm 4
Feb 17, 2026Vanessa BroadhurstVice presidentSale6,197$243.39$1.5MForm 4
Feb 13, 2026James D. SwansonVice presidentSale19,368$243.76$4.7MForm 4
Feb 13, 2026James D. SwansonVice presidentSale22,191$243.71$5.4MForm 4
Jan 26, 2026Joaquin DuatoCEOSale48,782$221.48$10.8MForm 4
Jan 26, 2026Joaquin DuatoCEOSale51,218$220.99$11.3MForm 4
Nov 26, 2025John G MorikisDirectorPurchase1,250$206.15$258KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Joaquin DuatoCEO and Chairman of the Board, Director–$66.8MAug 13, 2026
Joseph J WolkExec VP, CFO–$21.8MFeb 17, 2026
James D. SwansonEVP, CIO–$15.1MFeb 17, 2026
Timothy SchmidEVP, WW Chair, MedTech–$15.1MSep 2, 2026
John C ReedEVP, Innovative Medicine, R&D–$13.1MFeb 17, 2026
Elizabeth ForminardEVP, Chief Legal Officer–$7.8MNov 12, 2026
Vanessa BroadhurstEVP, Global Corp Affairs–$7.3MJul 20, 2026
Jennifer L TaubertEVP, WWC. Innovative Medicine–$4MAug 17, 2026
Kathryn E WengelEVP, Chief TO and Risk Officer–$2.4MJun 11, 2026
Robert J DeckerVP Corporate Controller–$1MFeb 27, 2026
John G MorikisDirector$258K–Nov 26, 2025
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

JNJ short interest

Low short interest. 0.7% of JNJ shares are sold short: about 1 share in 141. Over the last 12 reports the number of shares short went down 26%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 17.07M JNJ shares were sold short, 0.7% of the shares outstanding, up 1.8% from the report before. At the average daily volume of 7.09M shares, buying them all back would take about 2.4 trading days (days to cover).

Shares short, % of all shares

0.71%May 15Oct 301.21%

Days to cover

2.4May 15Oct 303.9

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202617.07M0.71%+2%7.09M2.4
Oct 15, 202616.77M0.70%-24%8.52M2.0
Sep 30, 202622.07M0.92%+4%6.75M3.3
Sep 15, 202621.19M0.88%-2%5.81M3.6
Aug 31, 202621.67M0.90%+0%6.55M3.3
Aug 14, 202621.59M0.90%-15%6.48M3.3
Jul 31, 202625.41M1.05%-7%8.50M3.0
Jul 15, 202627.43M1.14%+3%7.47M3.7
Jun 30, 202626.58M1.10%-0%10.72M2.5
Jun 15, 202626.69M1.11%+14%7.40M3.6
May 29, 202623.41M0.97%+2%7.94M3.0
May 15, 202623.04M0.96%+3%7.54M3.1

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded JNJ

Since Nov 17, 2024, 22 members of Congress reported 25 purchases and 34 sales of JNJ. The latest was a sale by Thomas H. Kean, Jr. on Sep 30, 2026, reported Oct 30, 2026.

Purchases 25Sales 34

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Sep 30, 2026Thomas H. Kean, Jr. (R-NJ)Partial sale$1K–$15KSelfOct 30, 2026Report
Sep 8, 2026Lloyd Doggett (D-TX)Purchase$1K–$15KSelfOct 5, 2026Report
Aug 27, 2026Thomas H. Kean, Jr. (R-NJ)Partial sale$1K–$15KSelfSep 12, 2026Report
Aug 20, 2026John Boozman (R-AR)Partial sale$1K–$15KJointSep 11, 2026Report
Jul 30, 2026Richard McCormick (GA)Sale$1K–$15KSelfAug 14, 2026Report
Jun 29, 2026Thomas H. Kean, Jr. (R-NJ)Partial sale$1K–$15KSelfJul 15, 2026Report
Jun 9, 2026Lloyd Doggett (D-TX)Purchase$1K–$15KSelfJul 6, 2026Report
Jun 2, 2026Thomas H. Kean, Jr. (R-NJ)Partial sale$1K–$15KSelfJul 15, 2026Report
Mar 30, 2026Alan Armstrong (R-OK)Purchase$1K–$15KSelfJul 21, 2026Report
Mar 27, 2026Alan Armstrong (R-OK)Purchase$15K–$50KSelfJul 21, 2026Report
Mar 26, 2026Thomas H. Kean, Jr. (R-NJ)Partial sale$1K–$15KSelfApr 13, 2026Report
Mar 19, 2026John Boozman (R-AR)Partial sale$1K–$15KJointApr 14, 2026Report
Mar 19, 2026Richard McCormick (GA)Partial sale$1K–$15KSelfApr 7, 2026Report
Mar 10, 2026Lloyd Doggett (D-TX)Purchase$1K–$15KSelfApr 6, 2026Report
Jan 23, 2026Thomas H. Kean, Jr. (R-NJ)Partial sale$15K–$50KSelfFeb 19, 2026Report
Dec 18, 2025Julie Johnson (D-TX)Sale$1K–$15KJointJan 15, 2026Report
Dec 9, 2025Lloyd Doggett (D-TX)Purchase$1K–$15KSelfJan 2, 2026Report
Nov 20, 2025Thomas H. Kean, Jr. (R-NJ)Partial sale$15K–$50KSelfDec 19, 2025Report
Nov 13, 2025Julie Johnson (D-TX)Partial sale$1K–$15KJointDec 11, 2025Report
Nov 5, 2025Richard McCormick (GA)Purchase$1K–$15KSelfDec 9, 2025Report
Oct 31, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseNov 21, 2025Report
Oct 30, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseNov 21, 2025Report
Oct 30, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseNov 21, 2025Report
Oct 10, 2025Jared Moskowitz (D-FL)Partial sale$1K–$15KChildNov 22, 2025Report
Sep 23, 2025Val T. Hoyle (D-OR)Sale$1K–$15KSpouseOct 10, 2025Report
Aug 19, 2025Kelly Morrison (D-MN)Partial sale$1K–$15KSelfSep 11, 2025Report
Aug 14, 2025Julie Johnson (D-TX)Partial sale$1K–$15KJointSep 11, 2025Report
Aug 4, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseSep 12, 2025Report
Jul 31, 2025Thomas H. Kean, Jr. (R-NJ)Partial sale$15K–$50KSelfAug 20, 2025Report
Jun 24, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseAug 13, 2025Report
Jun 17, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseAug 13, 2025Report
Jun 16, 2025Scott Franklin (R-FL)Sale$15K–$50KJointJul 14, 2025Report
Jun 12, 2025Pete Sessions (R-TX)Sale$15K–$50KSpouseJun 21, 2025Report
Jun 10, 2025Lloyd Doggett (D-TX)Purchase$1K–$15KSelfJul 7, 2025Report
May 30, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$15K–$50KSelfJun 6, 2025Report
May 12, 2025Jefferson Shreve (R-IN)Sale$50K–$100KSelfJun 22, 2025Report
May 5, 2025Marjorie Greene (GA)Purchase$1K–$15KSelfMay 6, 2025Report
Apr 29, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfMay 6, 2025Report
Apr 21, 2025Bruce Westerman (R-AR)Sale$1K–$15KSelfMay 12, 2025Report
Apr 9, 2025Josh Gottheimer (D-NJ)Partial sale$1K–$15KJointMay 14, 2025Report
Apr 8, 2025Robert P. Bresnahan, Jr. (R-PA)Sale$1K–$15KSelfApr 28, 2025Report
Apr 1, 2025Julie Johnson (D-TX)Sale$1K–$15KJointMay 14, 2025Report
Mar 31, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$15K–$50KSelfApr 7, 2025Report
Mar 24, 2025George Whitesides (D-CA)Sale$100K–$250KSelfApr 23, 2025Report
Mar 19, 2025Sheri Biggs (R-SC)Sale$15K–$50KSpouseOct 5, 2025Report
Mar 7, 2025Josh Gottheimer (D-NJ)Partial sale$1K–$15KJointApr 10, 2025Report
Mar 5, 2025Jefferson Shreve (R-IN)Purchase$15K–$50KSelfApr 11, 2025Report
Mar 4, 2025Lloyd Doggett (D-TX)Purchase$1K–$15KSelfApr 7, 2025Report
Mar 3, 2025Bruce Westerman (R-AR)Purchase$1K–$15KSelfApr 16, 2025Report
Feb 24, 2025Jefferson Shreve (R-IN)Purchase$15K–$50KSelfMar 9, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Johnson & Johnson company events

Johnson & Johnson filed 8 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Oct 13, 2026.

  1. Oct 13, 2026ResultsReleased financial results. Filing
  2. Aug 4, 2026LeadershipThe Company announced that Jennifer Taubert will retire from her position as Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee effective September 1, 2026. Filing
  3. Jul 29, 2026AnnouncementShared information with investors. Filing
  4. Jul 28, 2026AnnouncementShared information with investors. Filing
  5. Jul 15, 2026ResultsReleased financial results. Filing
  6. Apr 28, 2026VoteReported shareholder vote results. Filing
  7. Apr 14, 2026AnnouncementJohnson & Johnson issued the attached press release (Exhibit 99.3) announcing that its Board of Directors declared a 3.1% increase in the quarterly dividend, from $1.30 per share to $1.34 per share, marking the 64th year of consecutive increases. Filing
  8. Jan 21, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

How Johnson & Johnson makes money

Innovative Medicine brought in 64% of Johnson & Johnson's revenue ($60.4B of $94.2B) in 2025. MedTech was next, at 36%.

By business segment, 2025

Innovative Medicine$60.4B · 64%
MedTech$33.8B · 36%

By region, 2025

United States$53.8B · 57%
Europe$21.5B · 23%
Asia-Pacific, Africa$14B · 15%
Western Hemisphere, excluding U.S.$4.9B · 5%

From Johnson & Johnson's annual report (10-K) for the year ended Dec 28, 2025, filed Feb 11, 2026. The company chooses how to group its revenue, so the parts differ from one company to the next. Read the filing · How the biggest companies make money

Johnson & Johnson financials

Famous investors that hold JNJ

10 of the 50 well-known investors we track reported holding JNJ in their latest 13F filing. The largest position is Ken Fisher's, worth $3.9B.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Fisher · Fisher Asset ManagementQ3 202614.84M$3.9B1.1%+11%
Jeremy Grantham · GMOQ3 20266.96M$1.8B4.0%-2%
Ken Griffin · Citadel AdvisorsQ3 20262.74M$726M0.4%+83%
Tom Gayner · Markel GroupQ3 2026610,800$162M1.3%No change
Ray Dalio · Bridgewater AssociatesQ3 2026547,531$145M0.6%-18%
Israel Englander · Millennium ManagementQ3 2026109,905$29.1M0.0%-82%
Paul Tudor Jones · Tudor Investment CorpQ3 202637,876$10M0.0%New
George Soros · Soros Fund ManagementQ3 202634,019$9M0.2%No change
Tom Russo · Gardner Russo & QuinnQ3 20261,112$294K0.0%No change
Bill Nygren · Harris Associates (Oakmark)Q3 2026858$227K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Johnson & Johnson (JNJ) stock

Who owns the most JNJ stock?

The largest reported owner of Johnson & Johnson (JNJ) is BlackRock, Inc., with 8.8% of the company. In total, 4,651 funds and institutions reported holding JNJ at the end of Q2 2026, together about 75% of the shares. See the largest owners.

Are JNJ insiders buying or selling?

In the last 12 months, JNJ insiders reported 1 open-market purchase worth $258K and 29 sales worth $154M. The latest trade was on Nov 12, 2026. See every trade.

What is the short interest in JNJ?

As of Oct 30, 2026, 17.07M JNJ shares were sold short, 0.7% of the shares outstanding, up 1.8% from the report before. At the average daily volume of 7.09M shares, buying them all back would take about 2.4 trading days (days to cover). See the history.

Have members of Congress traded JNJ?

Yes. 22 members of Congress reported 25 purchases and 34 sales of JNJ since Nov 17, 2024. The latest was reported on Oct 30, 2026. See the trades.

How does Johnson & Johnson make money?

Innovative Medicine brought in 64% of Johnson & Johnson's revenue ($60.4B of $94.2B) in 2025. MedTech was next, at 36%. See the full split.

Which famous investors hold JNJ?

10 of the 50 well-known investors we track reported JNJ in their latest 13F filing, including Ken Fisher, Jeremy Grantham, Ken Griffin. The largest position is worth $3.9B. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.